Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal Rosen

Showing results (51-60 of 207) with videos related to

Pageof 21
Sort By:
Angewandte Chemie (International Ed. in English)|March 20, 2003
Total synthesis as a resource in the discovery of potentially valuable antitumor agents: cycloproparadicicolKana Yamamoto, Robert M Garbaccio, Shawn J Stachel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Pulsatile administration of the epidermal growth factor receptor inhibitor gefitinib is significantly more effective than continuous dosing for sensitizing tumors to paclitaxelDavid B Solit, Yuhong She, Jose Lobo, et al.
Molecular Cell|February 19, 2021
Regulation of PTEN translation by PI3K signaling maintains pathway homeostasisRadha Mukherjee, Kiran G Vanaja, Jacob A Boyer, et al.
Chemistry & Biology|June 26, 2004
Targeting wide-range oncogenic transformation via PU24FCl, a specific inhibitor of tumor Hsp90Maria Vilenchik, David Solit, Andrea Basso, et al.
Cell Reports|June 19, 2026
Distinct ERK and PI3K dependencies mediate a heterogeneous response to RAS(ON) inhibition in KRAS-mutant colorectal cancerPhilip H Choi, Julia Meredith, Malvika Sharma, et al.
Molecular and Cellular Endocrinology|March 6, 2007
Uncoupling of hormone-dependence from chaperone-dependence in the L701H mutation of the androgen receptorKenneth Robzyk, Handy Oen, Grant Buchanan, et al.
Cancer Research|December 18, 2003
Combination treatment with 17-N-allylamino-17-demethoxy geldanamycin and acute irradiation produces supra-additive growth suppression in human prostate carcinoma spheroidsRichard Enmon, Wei-Hong Yang, Ase M Ballangrud, et al.
Cancer Research|November 25, 2003
The heat shock protein 90 inhibitor geldanamycin and the ErbB inhibitor ZD1839 promote rapid PP1 phosphatase-dependent inactivation of AKT in ErbB2 overexpressing breast cancer cellsWanping Xu, Xitong Yuan, Yun Jin Jung, et al.
EMBO Reports|November 15, 2014
SOS1 and Ras regulate epithelial tight junction formation in the human airway through EMP1Joanne Durgan, Guangbo Tao, Matthew S Walters, et al.
Cancer Research|January 18, 2008
Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to paclitaxelAyana Sawai, Sarat Chandarlapaty, Heidi Greulich, et al.
Pageof 21

Showing results (51-60 of 207) with videos related to

Sort By:
Pageof 21
Angewandte Chemie (International Ed. in English)|March 20, 2003
Total synthesis as a resource in the discovery of potentially valuable antitumor agents: cycloproparadicicolKana Yamamoto, Robert M Garbaccio, Shawn J Stachel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Pulsatile administration of the epidermal growth factor receptor inhibitor gefitinib is significantly more effective than continuous dosing for sensitizing tumors to paclitaxelDavid B Solit, Yuhong She, Jose Lobo, et al.
Molecular Cell|February 19, 2021
Regulation of PTEN translation by PI3K signaling maintains pathway homeostasisRadha Mukherjee, Kiran G Vanaja, Jacob A Boyer, et al.
Chemistry & Biology|June 26, 2004
Targeting wide-range oncogenic transformation via PU24FCl, a specific inhibitor of tumor Hsp90Maria Vilenchik, David Solit, Andrea Basso, et al.
Cell Reports|June 19, 2026
Distinct ERK and PI3K dependencies mediate a heterogeneous response to RAS(ON) inhibition in KRAS-mutant colorectal cancerPhilip H Choi, Julia Meredith, Malvika Sharma, et al.
Molecular and Cellular Endocrinology|March 6, 2007
Uncoupling of hormone-dependence from chaperone-dependence in the L701H mutation of the androgen receptorKenneth Robzyk, Handy Oen, Grant Buchanan, et al.
Cancer Research|December 18, 2003
Combination treatment with 17-N-allylamino-17-demethoxy geldanamycin and acute irradiation produces supra-additive growth suppression in human prostate carcinoma spheroidsRichard Enmon, Wei-Hong Yang, Ase M Ballangrud, et al.
Cancer Research|November 25, 2003
The heat shock protein 90 inhibitor geldanamycin and the ErbB inhibitor ZD1839 promote rapid PP1 phosphatase-dependent inactivation of AKT in ErbB2 overexpressing breast cancer cellsWanping Xu, Xitong Yuan, Yun Jin Jung, et al.
EMBO Reports|November 15, 2014
SOS1 and Ras regulate epithelial tight junction formation in the human airway through EMP1Joanne Durgan, Guangbo Tao, Matthew S Walters, et al.
Cancer Research|January 18, 2008
Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to paclitaxelAyana Sawai, Sarat Chandarlapaty, Heidi Greulich, et al.
Pageof 21